211 related articles for article (PubMed ID: 21476913)
1. Fibrogenesis in nonalcoholic steatohepatitis.
De Minicis S; Svegliati-Baroni G
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):179-87. PubMed ID: 21476913
[TBL] [Abstract][Full Text] [Related]
2. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
Gambino R; Musso G; Cassader M
Antioxid Redox Signal; 2011 Sep; 15(5):1325-65. PubMed ID: 20969475
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis.
Rombouts K; Marra F
Dig Dis; 2010; 28(1):229-35. PubMed ID: 20460917
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of disease progression in nonalcoholic fatty liver disease.
Jou J; Choi SS; Diehl AM
Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
[TBL] [Abstract][Full Text] [Related]
5. Liver fibrogenesis and metabolic factors.
Anty R; Lemoine M
Clin Res Hepatol Gastroenterol; 2011 Jun; 35 Suppl 1():S10-20. PubMed ID: 21742296
[TBL] [Abstract][Full Text] [Related]
6. Inflammation in nonalcoholic steatohepatitis.
Harmon RC; Tiniakos DG; Argo CK
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):189-200. PubMed ID: 21476914
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
[TBL] [Abstract][Full Text] [Related]
8. Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis.
van der Poorten D; George J
Clin Liver Dis; 2008 Nov; 12(4):805-24, ix. PubMed ID: 18984468
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and fibrogenesis in steatohepatitis.
Fujii H; Kawada N
J Gastroenterol; 2012 Mar; 47(3):215-25. PubMed ID: 22310735
[TBL] [Abstract][Full Text] [Related]
10. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
Spahr L; Rubbia-Brandt L; Hadengue A
Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
[TBL] [Abstract][Full Text] [Related]
11. Liver fibrosis: from the bench to clinical targets.
Pinzani M; Rombouts K
Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
[TBL] [Abstract][Full Text] [Related]
12. Role of adipocytokines in hepatic fibrogenesis.
Ikejima K; Okumura K; Kon K; Takei Y; Sato N
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S87-92. PubMed ID: 17567476
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
Cortez-Pinto H; Baptista A; Camilo ME; de Moura MC
Hepatogastroenterology; 2001; 48(37):87-90. PubMed ID: 11269008
[TBL] [Abstract][Full Text] [Related]
14. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
Carter-Kent C; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
[TBL] [Abstract][Full Text] [Related]
15. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis.
Kisseleva T; Brenner DA
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S73-8. PubMed ID: 17567473
[TBL] [Abstract][Full Text] [Related]
16. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
[TBL] [Abstract][Full Text] [Related]
17. Modulation of liver fibrosis by adipokines.
Marra F; Navari N; Vivoli E; Galastri S; Provenzano A
Dig Dis; 2011; 29(4):371-6. PubMed ID: 21894007
[TBL] [Abstract][Full Text] [Related]
18. Activin A in nonalcoholic fatty liver disease.
Yndestad A; Haukeland JW; Dahl TB; Halvorsen B; Aukrust P
Vitam Horm; 2011; 85():323-42. PubMed ID: 21353887
[TBL] [Abstract][Full Text] [Related]
19. Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis.
Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():44-7. PubMed ID: 16225472
[TBL] [Abstract][Full Text] [Related]
20. Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.
Washington K; Wright K; Shyr Y; Hunter EB; Olson S; Raiford DS
Hum Pathol; 2000 Jul; 31(7):822-8. PubMed ID: 10923919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
